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In eukaryotic cells, RNAs at various maturation and processing levels are dis-
tributed across cellular compartments. The standard approach to determine tran-
script abundance and identity in vivo is RNA sequencing (RNA-seq). RNA-seq
relies on RNA isolation from whole-cell lysates and thus mainly captures fully
processed, stable, and more abundant cytoplasmic RNAs over nascent, unsta-
ble, and nuclear RNAs. Here, we provide a step-by-step protocol for subcellular
RNA-seq (subRNA-seq). subRNA-seq allows the quantitative measurement of
RNA polymerase II–generated RNAs from the chromatin, nucleoplasm, and cy-
toplasm of mammalian cells. This approach relies on cell fractionation prior to
RNA isolation and sequencing library preparation. High-throughput sequenc-
ing of the subcellular RNAs can then be used to reveal the identity, abundance,
and subcellular distribution of transcripts, thus providing insights into RNA pro-
cessing and maturation. Deep sequencing of the chromatin-associated RNAs
further offers the opportunity to study nascent RNAs. Subcellular RNA-seq
libraries are obtained within 5 days. C© 2017 by John Wiley & Sons, Inc.
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INTRODUCTION
Eukaryotic genomes are pervasively transcribed by RNA polymerase II (Pol II), giving
rise to all messenger RNAs and a large set of non-coding RNAs (Djebali et al., 2013;
Jensen et al., 2013; Pelechano & Steinmetz, 2013). Nascent RNA is synthesized in a
chromatin environment by stable Pol II transcription complexes (Jonkers & Lis, 2015;
Venkatesh & Workman, 2015). At the poly-adenylation (pA) site, the nascent transcript
is cleaved and poly-adenylated. The RNA that has been properly processed, as controlled
by RNA surveillance mechanisms, is released into the nucleoplasm and further processed
before it is exported into the cytoplasm (Kilchert, Wittmann, & Vasiljeva, 2016). The
RNA export is tightly regulated in vivo and involves many export factors (Meinel &
Stra¨ßer, 2015; Oeffinger & Zenklusen, 2012; Wickramasinghe & Laskey, 2015). The
fully processed messenger RNA (mRNA) serves as a blueprint for protein synthesis in
the cytoplasm. Thus, Pol II transcripts at different processing and maturation levels are
distributed between distinct cellular compartments, mainly between chromatin (nascent
RNA), nucleoplasm (processed and unprocessed RNA), and cytoplasm (mature RNA)
(Fig. 4.29.1).
The standard approach to globally measure transcript abundance and identity is RNA
preparation coupled with high-throughput sequencing (RNA-seq) (Wang, Gerstein, &
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Figure 4.29.1 Schematic overview of the key steps of the subRNA-seq approach.
Snyder, 2009). The standard RNA-seq method relies on the preparation of whole-cell
lysates prior to RNA isolation. Therefore, the information about the subcellular location
of a given RNA is lost. Furthermore, the generation of whole-cell extracts also results in
sequencing libraries that are dominated by fully processed stable RNAs that mainly occur
in the cytoplasm. These cytoplasmic RNAs usually complicate the analysis of nascent
and unstable transcripts.
To overcome these limitations, new variants of the original RNA-seq method have been
recently developed by us and others (Bhatt et al., 2012; Conrad et al., 2014; Ferrari et al.,
2013; Mayer et al., 2015; Mondal, Rasmussen, Pandey, Isaksson, & Kanduri, 2010;
Pandya-Jones & Black, 2009; Tilgner et al., 2012; Weber, Ramachandran, & Henikoff,
2014; Zaghlool et al., 2013). A commonality among these approaches is that they rely
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Here we provide a step-by-step protocol for the genome-wide measurement of transcript
abundance and identity in different cellular compartments —chromatin, nucleoplasm,
cytoplasm—by subcellular RNA-seq (subRNA-seq). This approach combines effective
cell fractionation with robust and efficient sequencing library preparation to reveal the
relative abundance and the identity of transcripts in different cellular compartments.
subRNA-seq reveals the full spectrum of Pol II–synthesized RNAs, at different processing
levels, ranging from unprocessed nascent RNAs to fully processed cytoplasmic RNAs.
The approach has been successfully applied to HeLa S3 and HEK293T cells, and will be
readily applicable to other mammalian cell types (Mayer et al., 2015). Thus, subRNA-seq
represents a powerful genomic tool for the analysis of RNA processing and also provides
an opportunity to study nascent RNAs in a broad range of mammalian cell types.
BASIC
PROTOCOL 1
CELL FRACTIONATION AND RNA ISOLATION
The cell fractionation approach described here is based on protocols that have been
developed by us and others (Bhatt et al., 2012; Mayer et al., 2015; Pandya-Jones & Black,
2009; Wuarin & Schibler, 1994). It is most similar to the cell fractionation protocol that
we have established for human native elongating transcript sequencing (NET-seq; Mayer
& Churchman, 2016; Fig. 4.29.1). Cells are lysed and the cytoplasm is separated from
nuclei by centrifugation through a sucrose cushion. The nuclei pellet is washed to remove
cytoplasmic remnants prior to chromatin fractionation. The chromatin is separated from
the nucleoplasm in the presence of urea, the nonionic detergent Nonidet P-40 (NP-40),
and NaCl, as originally described by the Schibler lab (Wuarin & Schibler, 1994). Next,
the RNA is prepared in parallel from the chromatin, nucleoplasmic, and cytoplasmic
fractions. Remaining DNA is removed by a standard DNase I digest.
Cell fractionation is performed in the presence of the Pol II transcription inhibitor α-
amanitin (Brueckner & Cramer, 2008; Lindell, Weinberg, Morris, Roeder, & Rutter,
1970) and RNase inhibitors to avoid run-off transcription and RNA degradation during
sample processing, respectively.
We recommend monitoring the success of the cell fractionation experiment by west-
ern blot analysis (Fig. 4.29.2A) using antibodies against subcellular markers. This is
especially true when the cell fractionation approach is applied to new cell types.
Materials
Cultured mammalian cells: 1× 107 cells per experiment
Phosphate-buffered saline (PBS; Life Technologies, cat. no. 10010-023)
Cytoplasmic lysis buffer (see recipe)
Sucrose buffer (see recipe)
Nuclei wash buffer (see recipe)
Glycerol buffer (see recipe)
Nuclei lysis buffer (see recipe)
TRI reagent (MRC, cat. no. TR 118)
Chloroform (Sigma, cat. no. 288306)
RLT buffer (Qiagen, cat. no. 79216)
100% (v/v) ethanol (VWR, cat. no. V1016)
RNeasy Mini Kit (Qiagen, cat. no.74104)
RNase-Free DNase Set (Qiagen, cat. no. 79254)
RNase/DNase-free H2O (Life Technologies, cat. no. 10977-015)
Antibodies (optional; for monitoring the experiment by western blotting):
Pol II Ser-2P antibody (3E8; Active Motif, cat. no. 61083)
Histone 2B antibody (FL-126; Santa Cruz Biotechnology, cat. no. sc-10808) Preparation and
Analysis of RNA
4.29.3
Current Protocols in Molecular Biology Supplement 120
Figure 4.29.2 Key quality controls and expected results from subRNA-seq experiments. (A) Representative
western blot of subcellular fractions. The different cellular fractions obtained from HeLa S3 cells were probed
against transcribing Pol II (Pol II Ser2-P; 3E8 antibody), the chromatin marker Histone 2B (FL-126 antibody),
the nucleoplasmic marker U1 snRNP70 (C-18 antibody), and the cytoplasmic marker GAPDH (6C5 antibody).
The volumes of the different cellular fractions have been adjusted so that the western blot signals can be
compared between the fractions. This figure was modified from Mayer et al. (2015). (B) Representative gels
showing the product of the reverse transcription (RT) of the samples (left panel) and of the oGAB11 controls
(right panel). The region that is excised from the gel is indicated by a blue bar or yellow star for the samples
and the oGAB11 controls, respectively. (C) Distributions of the size-normalized ratio of subRNA-seq reads that
map to exons versus introns for each gene. subRNA-seq libraries were generated from HeLa S3 cells. This
figure was adapted from (Mayer et al., 2015).
U1 snRNP70 antibody(C-18; Santa Cruz Biotechnology, cat. no. sc-9571)
GAPDH antibody (6C5; Life Technologies, cat. no. AM4300)
Cell scrapers
Refrigerated centrifuge
Additional reagents and equipment for basic cell culture techniques including
counting cells (Phelan & May, 2017) and for western blotting (immunoblotting;
UNIT 10.8, Ni., Xu, and Gallagher, 2016)
Cell fractionation
All experimental steps of the cell fractionation are performed on ice or at 4°C. Pre-cooled
buffers are used.
1. Use 1× 107 cells as an input per experiment.
The amount of input refers to HeLa S3 and HEK293T cells. Although we expect that the
number of cells required for a successful subRNA-seq experiment should be similar for
other mammalian cell types, in some cases protocol adjustments might be necessary, as
described in the Commentary section. We recommend determining the number of cells
by cell counting (APPENDIX 3F; Phelan & May, 2017).
2. Wash cells twice, each time with 10 ml PBS.
3. Scrape cells into 9 ml PBS.
This experimental step refers to cells that grow adherently or semi-adherently.
4. Centrifuge 2 min at 500 × g, 4°C. Discard supernatant.
5. Resuspend cell pellets in 200 µl cytoplasmic lysis buffer using pipet tips that have
been widened by cutting the narrow end off.
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7. Layer the cell lysate onto 500 µl sucrose buffer using pipet tips that have been
widened by cutting the narrow end off.
8. Centrifuge 10 min at 16,000 × g, 4°C.
9. Transfer the supernatant to a new tube and store on ice until further processed (see
step 23).
The supernatant represents the cytoplasmic fraction.
10. Wash nuclei pellet with 800 µl nuclei wash buffer.
11. Centrifuge 1 min at 1,150 × g, 4°C. Discard supernatant.
12. Cut tips and gently resuspend nuclei in 200 µl glycerol buffer.
13. Add 200 µl nuclei lysis buffer.
14. Mix by pulse vortexing and incubate on ice for 2 min.
15. Centrifuge 2 min at 18,500 × g , 4°C.
16. Transfer the supernatant to a new tube and store on ice until further processed (see
step 23), and also keep the pellet.
The supernatant and pellet represent the nucleoplasmic and chromatin fraction, respec-
tively.
Isolation of chromatin-associated, nucleoplasmic, and cytoplasmic RNAs
Chromatin RNA
17. Add 50 µl pre-cooled PBS to the chromatin pellet (from step 16) and resuspend by
pipetting.
18. Add 500 µl TRI reagent and resuspend the pellet by vortexing.
19. Add 100 µl chloroform, vortex, and incubate at room temperature for 5 min.
20. Centrifuge 15 min at 16,000 × g, 4°C.
21. Transfer the upper aqueous layer to a new tube, add 3.5 sample volumes of RLT
buffer, and mix.
22. Add 2.5 times the initial sample volume (before the RLT buffer was added) of
ice-cold 100% (v/v) ethanol and mix. Proceed with step 25.
Cytoplasmic and nucleoplasmic RNA
23. Add 3.5 sample volumes of RLT buffer and mix.
24. Add 2.5 times the initial sample volume (before the RLT buffer was added) of
ice-cold 100% (v/v) ethanol and mix. Proceed with step 25.
Chromatin, cytoplasmic, and nucleoplasmic RNA
25. Follow clean up protocol of the RNeasy Kit (Qiagen) according to manufacturer’s
instructions.
26. Perform an on-column DNase I digest (using Qiagen RNase-free DNase set) ac-
cording to manufacturer’s instructions.
27. Elute in 50 µl RNase/DNase-free H2O.
Proceed with the sequencing library preparation immediately or store the RNA at −80°C. Preparation and
Analysis of RNA
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The RNA concentration as determined by NanoDrop spectrophotometer measurement for
the cytoplasmic, nucleoplasmic, and chromatin fractions is typically 3000 to 4000, 600




The second part of the subRNA-seq approach exploits an efficient sequencing library
preparation method. The library preparation is based on protocols that we developed for
the human NET-seq approach (Mayer & Churchman, 2016; Mayer et al., 2015) and is
also related to generation of libraries used for yeast NET-seq (Churchman and Weissman,
2012a,b) and ribosome profiling (Ingolia, Brar, Rouskin, McGeachy, & Weissman, 2012).
Here, the chromatin, nucleoplasmic, and cytoplasmic RNAs obtained in Basic Protocol
1, steps 1 to 27, are converted into DNA sequencing libraries. This is accomplished by the
following major steps: (1) ribosomal RNAs (rRNAs) are depleted from the subcellular
RNAs using a commercially available removal kit; (2) RNA is fragmented by partial
alkaline hydrolysis; (3) 3′-phosphate groups are removed from the fragmented RNA;
(4) a barcoded DNA linker is ligated to the 3′-ends of the RNA; (5) RNA is converted
into cDNA; (6) circularized; and (7) amplified using a limited number of PCR cycles
(Fig. 4.29.1).
Each of these key steps has been optimized to work at a high efficiency, and success is
monitored by quality controls. If the library passes all quality checks, it is subjected to
an Illumina high-throughput sequencing platform such as MiSeq, HighSeq, or NextSeq.
Although we describe a NET-seq-based library preparation method here, we expect
that our cell fractionation and RNA isolation approach (Basic Protocol 1) can also be
combined with alternative library preparation protocols to obtain sequencing libraries.
Materials
RNA (Basic Protocol 1)
Ribo-Zero rRNA Removal Kit (Epicentre, cat. no. MRZH116)
80% (v/v) ethanol (VWR, cat. no. V1016)
RNase/DNase-free H2O (Life Technologies, cat. no. 10977-015)
50% PEG8000 (supplied with the truncated T4 RNA Ligase 2; NEB, cat. no.
M0242S)
Dimethylsulfoxide (DMSO; Sigma, cat. no. D8418)
T4 RNA Ligase buffer, 10× (supplied with the truncated T4 RNA Ligase 2; NEB,
cat. no. M0242S)
EDTA (0.5 M; Life Technologies, cat. no. AM9260G)
Alkaline fragmentation solution (see recipe)
RNA precipitation solution (see recipe)
RNA control ladder (0.1 to 2 kb; Life Technologies, cat. no. 15623-100)
oGAB11 control (Table 4.29.1)
2× TBU denaturing loading buffer (Life Technologies, cat. no. LC6876)
TBE-urea gels, 15% (w/v) (Life Technologies, cat. no. EC68852BOX)
Gel staining solution (see recipe)
GlycoBlue (15 mg/ml; Life Technologies, cat. no. AM9515)
Sodium acetate, RNase-free (3 M, pH 5.5; Life Technologies, cat. no. AM9740)
Isopropanol (Sigma, cat. no. 278475)
T4 PNK buffer, 10× (supplied with T4 Polynucleotide Kinase, NEB, cat. no.
M0201S)
SUPERase.In (20 U/µl; Life Technologies, cat. no. AM2696)
T4 Polynucleotide Kinase (10,000 U/ml; NEB, cat. no. M0201S)
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oLSC007 (RT primer)d,e /5Phos/ATCTCGTATGCCGTCTTCTGCTTG/iSp18/CA
CTCA/iSp18/TCCGACGATCATTGATGGTGCCTACAG
oNTI231 (reverse primer) CAAGCAGAAGACGGCATACGA
oLSC006 (sequencing primer) TCCGACGATCATTGATGGTGCCTACAG
RNA oligos




cCommercially available from Integrated DNA Technologies.
d5Phos: 5′-phosphate.
eiSp18: internal 18-atom hexa-ethylenglycol spacer.
f3Phos: 3′-phosphate.
T4 RNA Ligase 2, truncated (NEB, cat. no. M0242S)
5× First-Strand Buffer (part of SuperScript III First-Strand Synthesis System; Life
Technologies, cat. no. 18080-051)
dNTP mix (10 mM each dNTP; Life Technologies, cat. no. 18427-013)
DTT (0.1 M; part of the SuperScript III First-Strand Synthesis System, Life
Technologies, cat. no. 18080-051)
SUPERase.IN/DTT mix (see recipe)




DNA control ladder (10 bp; Life Technologies, cat. no. 10821-015)
TBE-urea gels, 10% (w/v) (Life Technologies, cat. no. EC68752BOX)
TBE buffer, 10× (Life Technologies, cat. no. 15581-044)
Gel staining solution (see recipe)
5 M NaCl
10 mM TrisCl, pH 8.0 (APPENDIX 2)
CircLigase reaction buffer, 10× (part of CircLigase ssDNA Ligase, Epicentre, cat.
no. CL4111K)
ATP, 1 mM (supplied with CircLigase ssDNA Ligase, Epicentre, cat. no. CL4111K)
MnCl2, 50 mM (supplied with CircLigase ssDNA Ligase, Epicentre, cat. no.
CL4111K)
CircLigase ssDNA Ligase (100 U/µl; Epicentre, cat. no. CL4111K)
Phusion HF Buffer, 5× (supplied with Phusion High-Fidelity DNA Polymerase,
NEB, cat. no. M0530S)
Illumina index primer (for example Barcode 4 Illumina index primer:
AATGATACGGCGACCACCGAGATCTACACGATCGGAAGAGCA-
CACGTCTGAACTCCAGTCACTGACCATCCGACGATCATTGATGG)
Phusion DNA Polymerase (2,000 U/ml; NEB, cat. no. M0530S)
6× DNA loading dye (UNIT 10.2A; Gallagher, 2012)
TBE gels, 8% (w/v) (Life Technologies, cat. no. EC62152BOX)
DNA soaking buffer (see recipe)
Qubit dsDNA HS Assay Kit (Life Technologies, cat. no. Q32851)









Blue or UV light source
Scalpels (Electron Microscopy Sciences, cat. no. 72042-11)
0.5-ml and 1.5-ml RNase/DNase-free non-stick microcentrifuge tubes
20-G needle (BD, cat. no. 305175)
Microcentrifuge tube filter: Costar Spin-X centrifuge tube filters (Sigma, cat. no.
CLS8162-96EA)
0.2-ml PCR tubes
Additional reagents and equipment for polyacrylamide gel electrophoresis (UNIT
10.2A; Gallagher, 2012)
rRNA depletion
In order to increase the fraction of informational sequencing reads that originate from
Pol II-synthesized transcripts, ribosomal RNAs are depleted. The rRNA depletion is
optional.
1. Use 20 µg of RNA as input per depletion.
2. Apply the Ribo-Zero rRNA Removal Kit and follow the manufacturer’s instructions
to deplete the ribosomal RNA.
3. Following the RNA precipitation (as described in the manufacturer’s instructions),
centrifuge 30 min at 20,000 × g, 4°C. Discard supernatant.
4. Wash RNA pellet with 750 µl pre-cooled 80% (v/v) ethanol, microcentrifuge briefly
to bring liquid to bottom of tube, and discard supernatant.
5. Repeat ethanol wash (step 4) one more time.
6. Air-dry pellet at room temperature for approximately 10 min.
7. Resuspend the RNA pellet in 10 µl RNase/DNase-free H2O.
Proceed with RNA fragmentation immediately or store at −80°C.
RNA fragmentation
RNA fragmentation is performed by partial alkaline hydrolysis as described in detail
in the human and yeast NET-seq protocols (Churchman & Weissman, 2012b; Mayer
& Churchman, 2016). The fragmentation time needs to be adjusted for new batches
of alkaline fragmentation solution. The length of the majority of the fragmented RNA
should be in the range that is excised from the polyacrylamide gel, as described below.
8. Denature 3 µg of rRNA-depleted RNA for 2 min at 80°C and microcentrifuge
briefly to bring liquid to bottom of tube.
9. Prepare the fragmentation mix as follows:
Component Amount per reaction (µl) Final
PEG8000 (50% v/v) 8.0 20% (v/v)
DMSO 2.0 10% (v/v)
T4 RNA Ligase buffer (10×) 2.0 1×
EDTA (0.5 M) 0.7 17.5 mM
RNA (1 µg/µl; from step 8) 1.0 1 µg
RNase/DNase-free H2O 6.3
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10. Add 20 µl of 2× alkaline fragmentation solution to each sample and mix.
11. Fragment RNA for the adjusted time at 95°C in a thermal cycler. Place immediately
on ice.
The fragmentation time needs to be adjusted for each new batch of alkaline fragmentation
solution. Fragmentation times between 10 to 40 min should be tested. The size of most
RNA fragments should be between 30 and 100 nt.
12. Add sample to 562µl of RNA precipitation solution and mix. Add 750µl isopropanol
and mix. Precipitate the fragmented RNA for 1 hr at −80°C.
13. Centrifuge 30 min at 20,000 × g, 4°C.
14. Discard supernatant and wash RNA pellet with 750 µl of 80% (v/v) ice-cold ethanol.
15. Air-dry RNA pellet for 10 min at room temperature
16. Resuspend pellet in 10 µl RNase/DNase-free H2O.
17. Prepare the RNA control ladder and the oGAB11 control (Table 4.29.1). Typically,
add 9 µl of RNase/DNase-free H2O to 1 µl RNA control ladder and to 1 µl (10 µM)
oGAB11. Add 10 µl of 2× TBU denaturing loading buffer to the RNA sample, the
RNA control ladder, and the oGAB11 control.
18. Denature the RNA sample, the RNA control ladder, and the oGAB11 control for
2 min at 80°C.
19. Pre-run a 15% TBE-urea polyacrylamide gel for 15 min at 200 V according to the
manufacturer’s instructions.
20. Load the fragmented RNA sample and the RNA control ladder and run the 15%
TBE-urea gel for 65 min at 200 V in 1× TBE (also see UNIT 10.2A; Gallagher, 2012).
21. Stain the gel for 5 min at room temperature in the gel staining solution and visualize
the fragmented RNA, the RNA control ladder, and the oGAB11 control under blue
or UV light. Excise the fragmented RNA between 30 and 100 nt.
Rapid gel extraction of the fragmented RNA
The rapid gel extraction approach is based on a protocol originally developed by Ingolia
et al. (2012) and is described in detail by Mayer & Churchman (2016).
22. Pierce a 0.5-ml RNase/DNase-free non-stick tube with a 20-G needle and place it
inside a 1.5-ml RNase/DNase-free non-stick tube. Transfer the gel slice into the
pierced 0.5-ml RNase/DNase-free non-stick tube. Centrifuge for 3 min at 20,000 ×
g, room temperature.
23. Add 200 µl RNase/DNase-free H2O and incubate for 10 min at 70°C. Vortex for
30 sec.
24. Transfer the gel slurry to a microcentrifuge tube filter (Costar Spin-X). Centrifuge
for 3 min at 20,000 × g, room temperature.
25. Combine the three eluates per sample (600 µl) and transfer to a new 1.5-ml
RNase/DNase-free non-stick tube. Add 2 µl GlycoBlue (15 mg/ml) and 50 µl of
3 M sodium acetate (pH 5.5). Mix well. Add 750 µl isopropanol and mix. Incubate
for 1 hr at −80°C.
26. Recover the RNA as described in steps 13 to 15.
27. Resuspend the RNA pellet in 22.5 µl RNase/DNase-free H2O.
The sample can be stored up to 3 months at −80°C. Preparation andAnalysis of RNA
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3′ RNA dephosphorylation
RNA fragmentation by partial alkaline hydrolysis not only results in RNA molecules with
a 3′-OH but also generates RNAs that contain a 3′-phosphate. The 3′-phosphate would
prevent a successful DNA linker ligation, and therefore needs to be removed before
ligation. This is accomplished by enzymatic dephosphorylation using T4 Polynucleotide
Kinase (PNK). The T4 PNK catalyzes 3′ RNA dephosphorylation in the absence of ATP.
The dephosphorylation procedure described here is based on a protocol published by the
Weissman lab (Ingolia, Brar, Rouskin, McGeachy, & Weissman, 2013). The success of the
enzymatic 3′ RNA dephosphorylation can be monitored by using the 3′-phosphorylated
RNA control oligo oGAB11-P (Table 4.29.1, Fig. 4.29.2B, right panel).
28. Prepare the T4 PNK reaction mix as follows:
Component Amount for two reactions (µl) Final
T4 PNK buffer, 10× 10 2×
SUPERase.In (20 U/µl) 2 40 U
RNase/DNase-free H2O 37.5
29. Denature 22.5µl of fragmented RNA (from step 27) and 22.5µl (0.1µg) of oGAB11-
P control oligo for 2 min at 80°C. Cool the denatured RNA on ice for 3 min.
30. Add 25 µl T4 PNK reaction mix (from step 28) to each tube and mix. Add 2.5 µl
T4 PNK (10 U/µl) and carefully mix.
31. Incubate the samples for 1 hr at 37°C followed by 10 min at 75°C to inactivate the
T4 PNK enzyme.
32. Add 450 µl RNase/DNase-free H2O, 56 µl of 3 M sodium acetate, and 2 µl of
15 mg/ml GlycoBlue, and mix. Add 600 µl isopropanol and mix.
33. Precipitate the 3′ dephosphorylated RNA and the dephosphorylated oGAB11 control
for 1 hr at −20°C.
34. Recover the RNA and the dephosphorylated oGAB11 control as described in steps
13 to 15.
35. Resuspend pellets in 6 µl pre-cooled RNase/DNase-free H2O.
Ligation of DNA linker-1
36. Denature dephosphorylated RNA, the dephosphorylated oGAB11 control (from step
35), and the oGAB11 control (1 µg in 6 µl; Table 4.29.1) for 2 min at 80°C.
37. Prepare the linker ligation mix for the RNA sample, the dephosphorylated oGAB11
control, and the oGAB11 control as follows:
Component Amount per reaction (µl) Final
PEG8000 (50% v/v) 8.0 20% (v/v)
DMSO 2.0 10% (v/v)
T4 RNA Ligase buffer (10×) 2.0 1×
DNA linker-1 (1 µg) 1.0
RNA sample/oGAB11 controls 6.0
Truncated T4 RNA Ligase 2 1.0 200 U
38. Perform the ligation reaction for 3 hr at 37°C. Add 0.7 µl of 0.5 M EDTA and mix
to stop the ligation.
39. Add 562 µl RNA precipitation solution and mix. Add 750 µl isopropanol and mix.
40. Precipitate the linker-ligated RNA and the oGAB11 controls for 1 hr at −20°C.
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42. Resuspend pellets in 10 µl RNase/DNase-free H2O.
Reverse transcription
43. Prepare the reverse transcription mix as follows:
Component Amount per reaction (µl) Final
5× First-Strand Buffer 3.3 1×
dNTPs (10 mM) 0.8 0.5 mM
RT primer oLSC007 (10 µM) 0.5 0.3 µM
44. Add 10 µl of linker-ligated RNA or of the linker-ligated oGAB11 controls (step 42),
mix, and incubate for 2 min at 80°C. Put the sample on ice for 3 min.
45. Add 1.3 µl SUPERase.IN/DTT mix to each tube and mix. Add 0.8 µl of SuperScript
III (200 U/µl) and mix.
46. Incubate the reverse transcription mixture for 30 min at 48°C. Add 1.8 µl of 1 N
NaOH, mix, and incubate for 20 min at 98°C. Neutralize the reaction by adding
1.8 µl of 1 N HCl, mix and put on ice.
47. Add 20 µl of 2× TBU denaturing loading buffer to each tube and mix.
48. Also prepare the DNA control ladder by adding 1.0 µl of DNA control ladder to 9 µl
RNase/DNase-free H2O. Add 10 µl of 2× TBU denaturing loading buffer and mix.
49. Denature the cDNA samples (including the oGAB11 controls) and the DNA control
ladder for 3 min at 95°C. Put the samples on ice for 3 min.
50. Pre-run a 10% (w/v) polyacrylamide TBE-urea gel at 200 V for 15 min in 1× TBE
buffer.
51. Separate the cDNA samples and the DNA control ladder by PAGE at 200 V for
65 min (also see Gallagher, 2012).
52. Stain the gel in 50 ml of gel staining solution for 5 min at room temperature.
The signal intensity of the dephosphorylated oGAB11 control and of the oGAB11 control
should be similar, indicating a high dephosphorylation efficiency (Fig. 4.29.2B, right
panel).
53. Excise the cDNA of the original RNA sample between 85 to 160 nt (Fig. 4.29.2B,
left gel; labeled with a blue bar). Also excise the distinct band of the oGAB11
control (Fig. 4.29.2B, right gel; band is labeled with a yellow asterisk). Transfer
the gel slices to two pierced (as described in step 22) 0.5-ml RNase/DNase-free
tubes. Put each 0.5 ml RNase/DNase-free tube into a 1.5 ml RNase/DNase-free
microcentrifuge tubes. Centrifuge for 3 min at 20,000 × g, room temperature.
The excision of the dephosphorylated oGAB11 control is optional.
54. Add 200 µl RNase/DNase-free H2O to each tube and incubate for 10 min at 70°C.
Vortex for 30 sec and transfer the gel slurry to microcentrifuge tube filters. Centrifuge
3 min at 20,000 × g, room temperature.
55. Transfer the eluate to a new 1.5-ml RNase/DNase-free non-stick tube. Add 2 µl
GlycoBlue (15 mg/ml) and 15 µl of 5 M NaCl, and mix.
56. Add 750 µl isopropanol and mix. Precipitate cDNA for1 hr at −20°C. Centrifuge
for 30 min at 20,000 × g, 4°C. Remove supernatant and wash the cDNA pellet with
750 µl pre-cooled 80% (v/v) ethanol.
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cDNA circularization and PCR amplification
58. Prepare the circularization mix for the cDNA sample and the oGAB11 control as
follows:
Component Amount per reaction (µl) Final
CircLigase 10× Reaction Buffer 2.0 1×
ATP (1 mM) 1.0 50 µM
MnCl2 (50 mM) 1.0 2.5 mM
59. Add 4 µl of circularization mix to 15 µl of cDNA sample and the oGAB11 control
(step 57) and mix. Add 1 µl (100 U) of CircLigase and mix.
60. Incubate 60 min at 60°C followed by 10 min at 80°C.
The circularized cDNA can be stored at −20°C up to 1 year, if not proceeding immediately
to the following steps.
61. Prepare PCR master mixes for four test reactions for the cDNA sample and for the




Phusion HF Buffer, 5× 18 1×
dNTPs (10 mM) 1.8 0.2 mM
Forward primer (Illumina Index primer,
100 µM)
0.45 0.5 µM
oNTI231 (reverse primer, 100 µM) 0.45 0.5 µM
DNase-free H2O 63.9
Phusion DNA Polymerase (2 U/µl) 0.9 1.8 U
The oGAB11 control serves as a positive control for the PCR amplification.
62. For each reaction, place 19 µl PCR master mix into a 0.2-ml PCR tube. Add 1.0 µl
circularized cDNA from the original RNA sample or from the oGAB11 control (step
60) and mix.
63. Perform PCR test amplifications as follows:
Cycle number Denature Anneal Extend
1 98°C, 30 sec
2-14 98°C, 10 sec 60°C, 10 sec 72°C, 5 sec
Stop the PCR amplification by removing the PCR tube at the end of the extension step,
typically after 6, 8, 10 and 12 rounds of amplification.
64. Add 3.4 µl 6× DNA loading dye to each completed PCR reaction and mix. Prepare
DNA control ladder. Add 1.0 µl DNA control ladder to 9 µl DNase-free H2O. Add
2 µl of 6× DNA loading dye and mix.
65. Load the PCR reactions and DNA control ladder on an 8% (w/v) TBE gel, and run
at 180 V for 45 min.
66. Stain the gel in 50 ml gel staining solution for 5 min at room temperature. Visualize
the gel and identify the optimal PCR amplification cycles for the cDNA sequencing
library.
At the optimal amplification cycle, a clear band at 120 nt is visible, whereas a DNA
smear that migrates slower in an 8% TBE-gel is absent.
67. Perform four PCR reactions per sample (not for the oGAB11 control) with the
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68. Excise the PCR product from the gel and transfer the gel slice into a pierced (see
step 22) 0.5-ml RNase/DNase-free tube. Put the 0.5 ml RNase/DNase-free tube into
a 1.5-ml RNase/DNase-free microcentrifuge tube. Centrifuge for 3 min at 20,000 ×
g, room temperature.
69. Add 670 µl DNA soaking buffer and mix. Incubate in a thermomixer at room
temperature overnight at 1500 rpm.
70. Transfer the gel slurry to a microcentrifuge tube filter and centrifuge for 3 min at
20,000 × g, room temperature.
71. Transfer the eluate to a new 1.5-ml RNase/DNase-free non-stick tube. Add 2 µl
GlycoBlue (15 mg/ml) and 680 µl isopropanol, and mix. Precipitate the subRNA-
seq library for 60 min at −20°C.
72. Centrifuge for 30 min at 20,000 × g, 4°C. Discard the supernatant and wash the
pellet with 750 µl 80% (v/v) ethanol. Air-dry pellet.
73. Resuspend the subRNA-seq library in 10 µl 10 mM Tris·Cl (pH 8.0).
The subRNA-seq library can be stored at −20°C up to 1 year, if not proceeding immedi-
ately.
74. Determine the quantity and quality of the subRNA-seq library by using the Qubit
dsDNA HS Assay Kit and the Agilent Bioanalyzer High Sensitivity DNA Analysis
Kit according to the manufacturer’s instructions.
The expected concentration is 30 to 70 nM. The subRNA-seq library is ready for high-
throughput sequencing on an Illumina sequencing platform using the custom sequencing
primer oLSC006 (Table 4.29.1).
REAGENTS AND SOLUTIONS
Use RNase- and DNase-free water in all recipes and experimental protocol steps.
Alkaline fragmentation solution, 2×
Composition is 100 mM NaCO3 (pH 9.2); for 5 ml, mix 0.6 ml of 0.1 M Na2CO3
and 4.4 ml of 0.1 M NaHCO3.Store in air-tight screw-cap tubes at room temperature
for up to 4 months.
Cytoplasmic lysis buffer
0.15% (v/v) NP-40 (Life Technologies, cat. no. 28324)
150 mM NaCl
25 µM α-amanitin (Sigma, cat. no. A2263)
10 U SUPERase.IN (add from 20 U/µl stock; Life Technologies, cat. no. AM2696)
1× cOmplete protease inhibitor mix, EDTA-free (Life Technologies, cat. no.
11873580001)
Prepare freshly before use and store on ice
DNA soaking buffer
For one reaction (668 µl), mix:
6.7 µl 1 M Tris·Cl, pH 8.0 (APPENDIX 2)
40 µl 5 M NaCl
1.3 µl 0.5 M EDTA (Life Technologies, cat. no. AM9260G)
620 µl RNase/DNase-free H2O (Life Technologies, cat. no. 10977-015)
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Gel staining solution
For 50 ml (enough for one gel): add 5 µl of SYBR Gold nucleic acid gel stain
(10,000× concentrate; Life Technologies, cat. no. S-11494) to 50 ml of 1× TBE
buffer (prepare from 10× TBE buffer; Life Technologies, cat. no. 15581-044). Pre-
pare this solution freshly before use and store protected from light at room tempera-
ture.
Glycerol buffer
20 mM Tris·Cl, pH 8.0 (APPENDIX 2)
75 mM NaCl
0.5 mM EDTA (Life Technologies, cat. no. AM9260G)
50% (v/v) glycerol
0.85 mM DTT
25 µM α-amanitin (Sigma, cat. no. A2263)
10 U SUPERase.IN (add from 20 U/µl stock; Life Technologies, cat. no. AM2696)
1× Protease inhibitor mix
Prepare freshly before use and store on ice
Nuclei lysis buffer
1% (v/v) NP-40
20 mM HEPES (pH 7.5)
300 mM NaCl
1 M urea
0.2 mM EDTA (Life Technologies, cat. no. AM9260G)
1 mM DTT
25 µM α-amanitin (Sigma, cat. no. A2263)
10 U SUPERase.IN (add from 20 U/µl stock; Life Technologies, cat. no. AM2696)
1× cOmplete protease inhibitor mix, EDTA-free (Life Technologies, cat. no.
11873580001)
Prepare freshly before use and store on ice
Nuclei wash buffer
1× phosphate-buffered saline (PBS; Life Technologies, cat. no. 10010-023)
containing:
0.1% (v/v) Triton X-100
1 mM EDTA (Life Technologies, cat. no. AM9260G)
25 µM α-amanitin (Sigma, cat. no. A2263)
40 U SUPERase.IN (add from 20 U/µl stock; Life Technologies, cat. no. AM2696)
1× cOmplete protease inhibitor mix, EDTA-free (Life Technologies, cat. no.
11873580001)
Prepare freshly before use and store on ice
RNA precipitation solution
For one reaction (562 µl): mix 60 µl of 3 M sodium acetate, pH 5.5 (Life Tech-
nologies, cat. no. AM9740), 2 µl of GlycoBlue (15 mg/ml; Life Technologies, cat.
no. AM9515), and 500 µl of RNase/DNase-free H2O (Life Technologies, cat. no.
10977-015). Prepare this solution freshly before use and store on ice.
Sucrose buffer
10 mM Tris·Cl, pH 7.0 (APPENDIX 2)
150 mM NaCl
25% (w/v) sucrose (Sigma, cat. no. S0389)
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20 U SUPERase.IN (add from 20 U/µl stock; Life Technologies, cat. no. AM2696)
1× cOmplete protease inhibitor mix, EDTA-free (Life Technologies, cat. no.
11873580001)
Prepare this buffer freshly before use and store on ice
SUPERase.IN/DTT mix
For one reaction (1.3 µl): mix 0.5 µl of SUPERase.IN (20 U/µl; Life Technologies,
cat. no. AM2696) and 0.8 µl of 0.1 M DTT. Prepare this solution freshly before use
and store on ice.
COMMENTARY
Background Information
High-throughput sequencing of subcellular
RNAs has been used by the authors of this
unit and others to study nascent transcription,
splicing, RNA processing, and RNA transport
and decay (Bhatt et al., 2012; Conrad, Mar-
sico, Gehre, & Ørom, 2014; Ferrari et al.,
2013; Khodor et al., 2011; Mayer et al., 2015;
Mondal et al., 2010; Pandya-Jones & Black,
2009; Tilgner et al., 2012; Weber et al., 2014;
Zaghlool et al., 2013). Most of these studies
have focused on specific subsets of RNAs such
as chromatin-associated RNAs (Khodor et al.,
2011; Mondal et al., 2010). However, a de-
tailed experimental protocol for the analysis
of the identity and abundance of the full spec-
trum of Pol II–synthesized RNAs in different
cellular compartments, ranging from unstable
chromatin-associated nascent RNAs to fully-
processed steady-state cytoplasmic RNAs, is
lacking.
Here, we provide step-by-step guidance
to interrogate RNAs in the chromatin, nu-
cleoplasmic, and cytoplasmic fractions of
mammalian cells. The subRNA-seq approach
combines effective cell fractionation with ef-
ficient and robust sequencing library prepara-
tion, thus providing a snapshot of the subcel-
lular distribution of RNAs at the time when
cells are lysed.
The cell fractionation is based on protocols
originally developed in the Schibler, Black,
and Smale laboratories (Bhatt et al., 2012;
Pandya-Jones & Black, 2009; Wuarin & Schi-
bler, 1994), and was optimized by us to mini-
mize cross-contamination of RNAs between
the different cellular compartments and to
avoid run-off transcription during sample pro-
cessing (Mayer et al., 2015). Cells are lysed
using the mild detergent NP-40, which keeps
the nuclear membrane intact. The released nu-
clei are separated from the cytoplasmic frac-
tion by centrifugation through a sucrose cush-
ion. The nucleoplasm is separated from the
chromatin in the presence of urea, NP-40,
and NaCl. This fast and effective chromatin
fractionation method exploits the high stabil-
ity of the Pol II transcription elongation com-
plex, even in the presence of high salt, de-
tergents and urea (Cai & Luse, 1987; Wuarin
& Schibler, 1994). In contrast to ionic deter-
gents, such as Sarkosyl, urea removes most of
the chromatin-associated proteins except for
transcribing RNA polymerase and histone pro-
teins (Khodor et al., 2011; Wuarin & Schibler,
1994). The chromatin is kept in a compacted
state that can be collected by low-speed cen-
trifugation. No ultracentrifugation is required.
The DNase-treated subcellular RNAs are
then applied to sequencing library prepara-
tion. The method described here is based on
protocols originally developed for NET-seq
(Churchman & Weissman, 2012a; Church-
man & Weissman, 2012b; Mayer & Church-
man, 2016; Mayer et al., 2015). In contrast
to the NET-seq approach, which relies on
high-throughput sequencing of the 3′-ends of
nascent transcripts, subRNA-seq sequences
across entire transcripts. The subRNA-seq li-
brary generation differs in two important ways
from the original NET-seq protocol:
1. RNA fragmentation is performed before
DNA linker-ligation.
2. The fragmented RNAs are dephospho-
rylated to generate an accessible 3′-OH prior
to the DNA linker ligation.
This library preparation method results
in DNA strand–specific sequencing libraries
for the cytoplasmic, nucleoplasmic, and
chromatin-associated RNAs, and are ready for
deep sequencing on Illumina platforms using
a custom sequencing primer.
The subRNA-seq approach has been suc-
cessfully used for the analysis of subcellu-
lar transcriptomes in HeLa S3 and HEK293T
cells (Mayer et al., 2015). In the meantime,
the authors have successfully applied the cell
fractionation approach to several other mam-
malian cell types including K562, MOLT4,
primary human foreskin fibroblasts (Padovan-
Merhar et al., 2015), and murine NIH/3T3
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critical for the success of a subRNA-seq ex-
periment, the authors expect that the protocol
described here should also be applicable to any
other mammalian cell type.
Critical Parameters and
Troubleshooting
subRNA-seq is a quantitative genome-wide
approach. This requires that each key step of
the protocol works as efficiently as possible.
The following steps of subRNA-seq are most
critical and their success needs to be moni-
tored.
Cell fractionation
Cell fractionation is the most critical step
of the subRNA-seq protocol and needs to
be as efficient as possible in order to avoid
cross-contamination between the subcellular
fractions. Although the cell fractionation pro-
tocol was extensively optimized (Mayer &
Churchman, 2016; Mayer et al., 2015), we
recommend monitoring its success by western
blotting using antibodies raised against sub-
cellular marker proteins such as GAPDH (cy-
toplasmic marker), U1 snRNP70 (nucleoplas-
mic marker), histone 2B (chromatin marker),
and transcribing RNA polymerase II (Pol II
Ser2-P, chromatin marker) (Fig. 4.29.2A).
When cytoplasmic marker proteins are de-
tected in the chromatin fraction, we recom-
mend reducing the amount of cells per frac-
tionation. Using more than 2 × 107 cells per
fractionation can reduce cell lysis efficiency
and thus disrupt effective fractionation. Fur-
thermore, we recommend completely remov-
ing the supernatant after washing the cell nu-
clei (Basic Protocol 1, step 11).
Strong western blot signals of transcribing
Pol II (Pol II Ser2-P) in the cytoplasmic frac-
tion indicate that the treatment during cell lysis
is too harsh, leading to dissociation of elongat-
ing Pol II from the chromatin. In this case, we
recommend carefully reducing the amount of
cell lysis buffer that is added to the cell pellet
(Basic Protocol 1, step 5).
Optionally, quantitative real-time PCR can
be performed to assess whether intron-
containing nascent RNAs are enriched in
the chromatin fraction. This can be ac-
complished by using primer pairs directed
against selected intronic and exonic regions
of well-expressed transcripts in the respec-
tive cell type of interest. Intron-containing
RNAs should be enriched in the chromatin
fraction, whereas intron-less, fully processed
RNAs should be prevalent in the cytoplasmic
fraction (Fig. 4.29.2C).
3′ RNA dephosphorylation
Only RNA molecules with a 3′-OH will
ligate with the DNA linker and be captured
in the sequencing library. In order to avoid
biases, and to make subRNA-seq a quantita-
tive approach, the removal of 3′-phosphates
should occur on 90% of the RNAs.
Therefore, we recommend monitoring the suc-
cess of 3′-dephosphorylation by using a 3′-
phosphorylated RNA control oligo (oGAB11-
P, Table 4.29.1 and Fig, 4.29.2B, right panel).
In the case of low dephosphorylation effi-
ciency, we recommend the following proto-
col adjustments: (i) increase the concentra-
tion of the T4 PNK, (ii) use a new batch of
T4 PNK (different lot number), (iii) increase
the T4 PNK treatment time, and (iv) decrease
the amount of RNA per dephosphorylation
reaction.
DNA linker ligation
Only RNA molecules that ligate to the DNA
linker are captured in the final subRNA-seq li-
brary, and therefore the ligation should be as
efficient as possible (90%). Only in this case
does the final subRNA-seq library quantita-
tively reflect the pool of RNAs in the orig-
inal sample. The ligation efficiency should
be tested by using the RNA control oligo
oGAB11 (Table 4.29.1 and Fig. 4.29.2). We
noticed that the ligation efficiency can vary
with different batches of the truncated T4 RNA
Ligase 2. We recommend keeping track of
the lot numbers of the ligase. Whenever the
ligation efficiency is below 90%, we recom-
mend using a new batch of enzyme (different
lot number). Furthermore, increasing the lig-
ase concentration and the ligation time can
enhance the ligation efficiency. We also rec-
ommend replacing components of the ligation
reaction every 4 months.
Anticipated Results
The RNA yield from the cytoplasmic, nu-
cleoplasmic, and chromatin fractions obtained
from 1× 107 HeLa S3 cells is 150 µg,
35 µg, and 25 µg, respectively. The
A260/A280 ratio is 2.1 as determined by Nan-
oDrop spectrophotometer measurement. The
efficiency of the 3′-dephosphorylation of frag-
mented RNA is typically 90% as monitored
by PAGE loading of the cDNA obtained from
the oGAB11-P and the oGAB11 RNA control
oligos (Table 4.29.1 and Fig. 4.29.2B, right
panel). The efficiency of the DNA linker liga-
tion is usually 95% as determined by PAGE
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4.29.1 and Fig. 4.29.2, right panel). The total
yield of a typical subRNA-seq library is 20
to 30 ng, as determined by Qubit fluorometer
and Bioanalyzer measurements. The average
fragment length of a subRNA-seq library is
150 nt. The RNA from the chromatin frac-
tion is enriched for intron-containing nascent
RNAs, as shown by a lower exon/intron ratio
as compared to RNAs from the nucleoplasmic
and cytoplasmic fractions (Fig. 4.29.2C).
Time Considerations
On day 1, cell fractionation (Basic Protocol
1, steps 1 to 16), RNA isolation (Basic Proto-
col 1, steps 17 to 25), DNase I digest (Basic
Protocol 1, steps 26 and 27), and rRNA de-
pletion (Basic Protocol 2, optional steps 1 to
7) are performed, which take approximately
6 hr. On day 2, the RNA is fragmented (Basic
Protocol 2, steps 8 to 27) and dephosphory-
lated (Basic Protocol 2, steps 28 to 35). This
will take approximately 5 to 6 hr. On day 3,
the DNA linker is ligated (Basic Protocol 2,
steps 36 to 42) and the cDNA synthesis (Basic
Protocol 2, steps 43 to 57) is conducted. This
requires 5 to 6 hr. On day 4, the cDNA is
circularized and the subRNA-seq libraries are
amplified by a limited number of PCR cycles
(Basic Protocol 2, steps 58 to 69). This will
take 6 hr and requires an overnight elution.
On day 5, subRNA-seq library preparation is
completed and the quality is monitored (Basic
Protocol 2, steps 70 to 74). This will require
2 to 3 hr. If the libraries pass the quality
control, they are ready for sequencing on the
Illumina sequencing platform.
The protocol includes many pausing points
and thus can be performed in a flexible manner
and according to the working habits of the
experimenter.
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